Posicor
On June 20, 1997, the FDA approved Posicor despite findings from a congestive heart failure study suggesting that it might fatally disrupt heart rhythm (arrhythmia) when used with other drugs. The 2,400-patient clinical study found that 142 patients suddenly died after taking either Posicor or a placebo. The patients given Posicor died at a rate about 10% greater than those who took a comparator...MORE >>
Featured Articles on Posicor
Browse Books About Drug Litigation
The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.
